 NEW YORK, Jan. 21, 2023 GLOBE NEWSWIRE Pomerantz LLP announces that a class action lawsuit has been filed against certain officers and directors of Fate Therapeutics, Inc. Fate or the Company NASDAQ: FATE. The class action, filed in the United States District Court for the Southern District of California, and docketed under 23-cv-111-WQH-NLS, is ... The post Pomerantz Law Firm Announces the Filing of a Class Action Against Certain Officers and Directors of Fate Therapeutics, Inc... 